PBMs and the drug pipeline: Anticipating tomorrow while affording today

October 04, 24

Biosimilars help lower costs and foster innovation in pharmacy benefits

By creating competition that can significantly reduce the prices of biologic medications, biosimilars create financial headroom for plan sponsors to offer coverage for innovative drug treatments.

September 30, 24

Providing a high level of customization and modularity to third-party administrators and health plans

September 16, 24

Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year

September 05, 24

Express Scripts continues efforts to lower drug costs and ensure streamlined patient access to innovative biosimilars

August 23, 24

How specialty pharmacy enhancements help physicians and patients navigate the prior authorization process

Digital tools and AI-enabled processes can help evolve prior authorizations to deliver the best outcomes for patients, providers and payers.

Jim Blondin, RPh, MBA, August 14, 24

PBM clients agree: Protect our pharmacy benefit tools

Express Scripts by Evernorth recently polled a group of more than 200 health benefit experts about the policy proposals being considered by Congress.

July 18, 24